investigated the effects of clozapine therapy on nocturnal growth hormone secretion and sleep architecture in five male schizophrenia inpatients compared with five healthy age- and sex-matched volunteers during an early therapy phase (within one week) and prolonged therapy (6–8 weeks) [26]. The gene discussed is GH1; the disease is schizophrenia.